The molecular technique of RNA fingerprinting was used to characterize the genomes of 5 isolates of bovine viral diarrhea virus (BVDV): 2 viral pairs from the same animal, BVD-ILN/BVD-ILC and BVD-TGAN/BVD-TGAC, and the cytopathic viral prototype, BVD-NADL. Oligonucleotide patterns from the viruses were compared, and unique and overlapping oligonucleotides were identified. A comparison of the fingerprints indicated that the genome of each virus was distinguishable by the Tl RNase oligonucleotide fingerprinting technique. The greatest similarity observed was between oligonucleotides from BVD-ILC and BVD-ILN. Eighteen large oligonucleotides were conserved in all 5 BVDV isolates studied. We found that within a pair of BVDV, the cytopathic fingerprint was different from the noncytopathic fingerprint, indicating that cytopathic and noncytopathic BVDV may be distinct viruses.
Bovine viral diarrhea virus (BVDV) is currently clas-pathic BVDV by the molecular technique of T1 RNase sified in the genus Pestivirus in the family Togaviri-oligonucleotide fingerprinting. dae. 18 Bovine viral diarrhea virus causes a variety of disease conditions in cattle, ranging from subclinical infections to severe clinical disease (mucosal disease) characterized by ulcerations on mucosal membranes in the gastrointestinal tract. 1, 16 Noncytopathic viral infections of the fetus before day 125 of gestation are associated with persistent infections and immunotolerante to BVDV. 13 Experimentally, it has been shown that cattle infected in utero with noncytopathic BVDV later develop clinical signs of mucosal disease when super-infected with certain cytopathic strains. 24 Thus, 2 biologically distinct BVDV, a cytopathic (CP) and noncytopathic (NCP) viral pair, are associated with mucosal disease. It has been suggested that mucosal disease may be the result of a NCP virus mutating to a CP virus. 5, 11 Recently, it has been suggested that a NCP BVDV mutates into a CP BVDV in persistently infected animals by acquiring cellular sequences from the host via recombination events. 14 
Materials and methods
Viruses and cells. All of the viruses were isolated from cows from geographically distinct areas of the US: BVD-NADL, Maryland in 1962; BVD-TGAC/TGAN, Georgia in 1983; and BVD-ILC/ILN, Illinois in 1981. Viruses BVD-ILN and BVD-ILC were isolated from a single animal during a spontaneous episode (not induced by vaccination) of mucosal disease. Likewise, viruses BVD-TGAN and BVD-TGAC were isolated from a single animal from another incidence of spontaneous mucosal disease.
The actual mechanisms responsible for the cytopathic and noncytopathic nature of BVDV and their correlation to the molecular biology of mucosal disease are not yet known. The objective of this study was to compare several isolates of cytopathic and noncyto-Monolayers of bovine thymus (B-Thy) cells were grown in 850-cm 2 roller bottles at 37 C and maintained on Eagle's Minimal Essential Medium (MEM) with 10% serum-allantoic fluid-500, a 0.02 mg/ml gentamycin, and 1% penicillinstreptomycin. Serum-allantoic fluid-500 is a blend of 50% fetal bovine serum and 50% bovine allantoic fluid that has been tested for BVDV by the fluorescent antibody technique. The B-Thy cell cultures were routinely checked for BVDV virus by the direct fluorescent antibody test (FAT) using fluorescein isothiocyanate-conjugated anti-BVDV serum. 6 Viruses were cloned by plaque selection or passaged at limiting dilutions and then replicated on confluent monolayers of B-Thy cells. The BVDV-infected cells were maintained on 2% horse serum in MEM. At 96 hr postinfection, at which time a marked cytopathic effect was seen in B-Thy CP-infected cells, the infected material was frozen at -20 C 
lysates of infected B-Thy cells by a low speed clarification
Received for publication May 10, 1990. and a high speed ultracentrifugation. Because BVDV adheres to cell surfaces, the virions were treated with bromelain c (an enzyme that cleaves external proteins) and then layered directly onto 20-50% weight by weight sucrose density gradients. 6 Gradients consisting of B-Thy-uninfected cell pellets were treated with bromelain as controls and run alongside all viral preparations. No bands were ever detected in cellular control gradients. Bromelain-treated viral bands were collected and concentrated in 0.1 M NaOAc, pH 5.2, and incubated at 37 C with 0.5 mg/ml proteinase K d for 30 min and then with 1% sodium dodecyl sulfate for 15 min. The BVDV RNA was extracted and digested with 5 units of Tl RNase d at 37 C for 90 min, and the 3' ends of the T1 RNasegenerated oligonucleotides were labeled with cytidine 3', 5'bis-(phosphate), e 5'-32 P (pCp) by a procedure previously described. 8 Tl RNase cleaves specifically at guanosines, creating oligonucleotidcs with 3' guanosine phosphates and 5' hydroxyls.
Genome differences for cytopathic and noncytopathic isolates were determined by studying oligonucleotide or "fingerprint" maps made from double-dimensional gel electrophoresis of the T1 RNase-digested BVDV RNA. Labeled oligonucleotides were resolved by 2-dimensional gel electrophoresis and visualized by autoradiography. 7, 8, 17 The BVDV RNA extracted from virus that was not treated with bromelain but was subsequently extracted and electroeluted from agarose gels produced similar results. 8 Oligonucleotide patterns from the 5 BVDV isolates were compared, and unique and overlapping oligonucleotides were identified (Figs. l-3). Schematics were drawn from the fingerprints for each isolate, and the percentages of oligonucleotides shared between the isolates were calculated and compared (Table 1) .
RNA fingerprinting should represent approximately 6.4% of the BVDV genome, provided that guanosine nucleotides are randomly distributed throughout the genome. 12 However, identical fingerprints do not necessarily reflect identical nucleotide sequences (a fingerprint may represent 10% of the differences found between 2 virus strains that are 90% homologous in nucleotide sequence to one another. 12
Results

Comparisons of pairs of BVDV isolatedfrom the same animal during outbreaks of mucosal disease. When
oligonucleotide fingerprint maps and schematics for BVD-ILC and BVD-ILN were compared, a 68% similarity was found. The percent similarity does not refer to the percent nucleotide homology; rather, it refers to the percentage of oligonucleotides shared between 2 BVDV fingerprint maps. Twenty-seven of 40 coincident oligonucleotides were shared by BVD-ILC and BVD-ILN ( Fig. l) , with 8 oligonucleotides being unique to BVD-ILC and 5 unique to BVD-ILN (Table 1) . When the fingerprints for BVD-TGAN and BVD-TGAC were compared, 29 of 57 were coincident oligonucleotides (51% similarity) ( Fig. 2) ; 16 oligonucleotides were unique to BVD-TGAC and 12 were unique to BVD-TGAN (Table 1 ). Furthermore, 4 oligonucleotides were found common only to BVDV Illinois isolates (BVD-ILN and BVD-ILC) and 2 oli- gonucleotides were found common only to Georgia isolates (BVD-TGAN and BVD-TGAC).
Comparisons of cytopathic and noncytopathic biotypes. Each virus isolate was compared to each of the other 4 viral isolates (Table 1) . Forty percent similarity (23 of 57) was detected between 2 of the cytopathic viruses, BVD-ILC and BVD-TGAC. Less similarity was detected between those cytopathic viruses and the cytopathic prototype virus, BVD-NADL. When these fingerprints were compared, 24 out of a total of 82 oligonucleotides were common to BVD-ILC and BVD- NADL (29%) and 29 out of a total of 87 oligonucleotides were common to BVD-TGAC and BVD-NADL (3 3%). The NCP isolates, BVD-TGAN and BVD-ILN, showed 49% similarity or had 24 common oligonucleotides out of a total of 49. No oligonucleotides were found common only to the CP or NCP isolates of BVDV.
Overall comparison of all 5 BVDV isolates. All of the BVDV RNAs exhibited some fingerprinting differences when compared with one another (Figs. l-3 ), but 18 large oligonucleotides were found conserved in all 5 viruses (Table 2 ). Each BVDV RNA had approx- imately the same oligonucleotide fingerprinting pattern except for the NADL, the cytopathic prototype (Fig.  3) . The total number of oligonucleotides for each fingerprinting pattern and the respective conserved oligonucleotides being compared were analyzed in Table  2 . The BVD-ILC had 35 oligonucleotides, BVD-ILN, 32, BVD-TGAC, 45, BVD-TGAN, 41, and BVD-NADL, 71. Because their fingerprinting patterns contained fewer oligonucleotides than the other BVDV fingerprints, the BVD-ILC and BVD-ILN viruses were used as a point of reference to study the other fingerprints. The percentages of oligonucleotides shared for all 5 BVDV viruses are shown in Table 1 . The highest percent similarity (68%) was observed between BVD-ILN and BVD-ILC and the lowest percent similarity was observed between BVD-NADL and the other 4 viruses. BVD-ILC showed a greater degree of similarity to BVD-ILN (68%) than it did to the other cytopathic biotypes (BVD-TGAC, 40%; BVD-NADL, 29%). BVD-ILN also showed a greater degree of similarity to BVD-ILC than to the other NCP biotype, BVD-TGAN (49%). Likewise, BVD-TGAC showed a greater degree of similarity to BVD-TGAN (51%) than it did to the other cytopathic biotypes, and BVD-TGAN was closer to BVD-TGAC (51%) than it was to the other NCP isolate, BVD-ILN (49%).
RNA genome evolution that is more than a millionfold higher than that of DNA evolution; consequently, the concept of "wild-type" RNA viruses may have little, if any, meaning for RNA genomes. 10 Multiple genetic changes, as many as 100 or greater, have occurred in oral poliovaccines upon replication in 1 or 2 individuals. 12 The differences observed among the BVDV fingerprints in the past 20 years may, in part, be due to high mutation frequencies observed in all RNA viruses, but also, in part, due to the the possibility that the viruses isolated from Georgia, Illinois, and Maryland come from differing parental strains of BVDV.
Although distinct differences were observed in all of the fingerprints analyzed, all 5 BVDV isolates were genotypically related; 18 large oligonucleotides were conserved, regardless of when or where they were isolated. The BVD-NADL prototype (Maryland, 1962) had 18 large oligonucleotides in common with all of the other BVDV isolates. These analyses indicate that BVD-ILC, BVD-ILN, BVD-TGAC, and BVD-TGAN are genotypically related to the NADL CP prototype, although the NADL fingerprint is the most diverse ( Fig. 3) .
Discussion
A comparison of the oligonucleotide fingerprints of BVD-ILC, BVD-ILN, BVD-TGAC, BVD-TGAN, and BVD-NADL (prototype virus) indicates that the genome fingerprints of BVDV from Illinois, Georgia, and Maryland are easily distinguished by T1 RNase oligonucleotide fingerprinting technique. The greatest similarity was observed between BVD-ILN and BVD-ILC (68%); less similarity was observed between NADL and the other viruses (29-33%) ( Table 1) .
Bovine viral diarrhea virus and other RNA viruses typically mutate at high frequencies because they lack the proofreading enzymes found in DNA replication. 10 The combined effects of high mutation frequencies and high numbers of replication events result in a rate of Viruses that have been isolated at the same time from different animals during the same outbreak of disease generally have similar fingerprints, whereas viruses isolated from an earlier or later outbreak will show increasing divergence? The BVDV isolates isolated in the 1980s show 40-68% similarity to one another, whereas BVD-NADL, isolated from an earlier outbreak, shows 29.33% similarity to the other fingerprints (Table 1 ). It is possible that BVD-NADL and the other isolates BVD-TGAC, BVD-TGAN, BVD-ILC, and BVD-ILN have undergone genomic evolution, resulting in accumulation of viable genome alterations. Accumulations of single base mutations, insertions, or recombination events with different endogenous virions may have contributed to alterations seen in all of the BVDV genomes.
The question of how CP and NCP isolates of BVDV interact within a host to cause the onset of mucosal disease remains unanswered. Several theories have been formulated throughout the past decade to explain the biology of mucosal disease. One theory proposes that mucosal disease occurs as a result of the super-infection of a cytopathic BVDV into a host persistently infected with a noncytopathic form of BVDV. 2, 4 This phenomenon has been reproduced experimentally. 2, 4 It has been suggested that mucosal disease occurs as a result of a noncytopathic virus mutating into a cytopathic virus within the host. 5, 11 This is supported by serologic studies that indicate that pairs of viruses from mucosal disease cases are more closely related than viruses from different sources. 11 Also, monoclonal antibody analysis shows that pairs of BVDV share common epitopes. 9 Alternatively, it has also been suggested that a NCP BVDV in a persistently infected animal mutates to a CP BVDV by acquiring cellular sequences from its host during recombination events. 14 The fact that our fingerprinting patterns from a pair of BVDV isolated from an individual animal affected with mucosal disease have a number of differences in their oligonucleotides might imply that a single, simple mutation has not occurred. If mucosal disease was, in fact, precipitated by a single mutational event where a NCP BVDV became cytopathic, we would predict that the fingerprinting patterns of a BVDV CP/NCP pair would be nearly identical. Even the high percentage of similarity as seen between BVD-ILN and BVD-ILC indicates relatively limited identity because 8 oligonucleotides found in BVD-ILC cannot be found in BVD-ILN and 5 oligonucleotides found in BVD-ILN cannot be found in BVD-ILC. However, it is possible that a cellular insertion, for example, of 250 bases into a NCP BVDV, could account for the differences that we observed between a pair of BVDV viruses. 14 The data presented in this report are consistent with the premise that mucosal disease is occurring as a result of super-infection of a distinct CP virus into a persistently infected seronegative animal. Alternatively, because of the likelihood of mutational events occurring, many genetically distinct noncytopathic viruses may infect a persistently infected bovine at any given time, thus the chance of isolating the true noncytopathic pair for a cytopathic virus may be small and detection of genomic differences by the fingerprinting procedure would be expected.
A high mutation rate may camouflage a specific alteration that could result in a subsequent change in the biotype of the virus; however, it would seem unlikely for random mutations or insertions in the NCP BVDV genome to consistently turn on the virulence factors that would lead to the onset of mucosal disease. More detailed molecular studies of CP/NCP BVDV pairs isolated from animals with mucosal disease may provide answers to the questions concerning the pathology and molecular biology of mucosal disease.
